Learn more about our China work.
WASHINGTON—AdvaMed, the MedTech Association®, called the U.S.-China trade announcement a positive step toward supporting the U.S.-led medtech industry and its service to patients nationwide and globally.
WASHINGTON – Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, today called for a reciprocal “zero for zero” model with respect to tariffs among U.S. trading partners for…
The AdvaMed® Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed® China Code” or “Code” – serves as a foundational charter for medical technology companies’…
The AdvaMed® Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed® China Code” or “Code” – serves as a foundational charter for medical technology companies’…
AdvaMed®’s office in China sits at the forefront of helping our members navigate China’s large, fast-growing market for medical technologies.
先进医疗技术协会在全球积极倡导先进医疗技术发展,以促进人类生命健康与各国经济发展。
AdvaMed® members work around the globe, so we do, too.
Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.
The Chinese government announced a process to export particular devices without NMPA approval.
WASHINGTON, D.C. – The Advanced Medical Association (AdvaMed®) requested the United States Trade Representative (USTR) provide additional tariff exclusions for medical devices, components and supplies coming from China needed in…